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Abstract
Background Cerebrospinal compliance describes the ability of the cerebrospinal space to buffer changes in volume. Diminished
compliance is associated with increased risk of potentially threatening increases in intracranial pressure (ICP) when changes in
cerebrospinal volume occur. However, despite various methods of estimation proposed so far, compliance is seldom used in
clinical practice. This study aimed to compare three measures of cerebrospinal compliance.
Methods ICP recordings from 36 normal-pressure hydrocephalus patients who underwent infusion tests with parallel recording
of transcranial Doppler blood flow velocity were retrospectively analysed. Three methods were used to calculate compliance
estimates during changes in the mean ICP induced by infusion of fluid into the cerebrospinal fluid space: (a) based on
Marmarou’s model of cerebrospinal fluid dynamics (CCSF), (b) based on the evaluation of changes in cerebral arterial blood
volume (CCaBV), and (c) based on the amplitudes of peaks P1 and P2 of ICP pulse waveform (CP1/P2).
Results Increase in ICP caused a significant decrease in all compliance estimates (p < 0.0001). Time courses of compliance
estimators were strongly positively correlated with each other (group-averaged Spearman correlation coefficients: 0.94 [0.88–
0.97] for CCSF vs. CCaBV, 0.77 [0.63–0.91] for CCSF vs. CP1/P2, and 0.68 [0.48–0.91] for CCaBV vs. CP1/P2).
Conclusions Indirect methods, CCaBV and CP1/P2, allow for the assessment of relative changes in cerebrospinal compliance and
produce results exhibiting good correlation with the direct method of volumetric manipulation. This opens the possibility of
monitoring relative changes in compliance continuously.
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Introduction
In adults, the skull is a closed non-distensible box filled with
three volume components: brain tissue, cerebral blood, and
cerebrospinal fluid (CSF) [16]. According to the Monro–
Kellie doctrine, in the long-term—and under normal
conditions—increases in the volume of one component are
compensated by decreases in the volume of another, maintain-
ing the total volume at an approximately constant level [20].
However, in the short-term scale, considering pulsatile blood
flow, for a part of the cardiac cycle, total blood volume in-
creases and then decreases, leaving total volume changes
equal to zero [2]. This produces rhythmic instability of the
intracranial pressure (ICP) signal, known as ‘pulse wave-
form’. The ability of the cerebrospinal space to accommodate
changes in volume is quantified by a parameter called com-
pliance which links changes in volume with corresponding
changes in pressure [23]. Low compliance puts the system at
risk of disproportionately large increases in ICP for even small
increases in intracranial volume, potentially leading to intra-
cranial hypertension [21]. To measure cerebrospinal compli-
ance, external gradual volume addition into the cerebrospinal
space is needed, which is a limitation preventing continuous
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monitoring.We aimed to examine and compare three methods
of assessment of cerebrospinal compliance. One is a ‘golden
standard’ based on external volume load, and two others rely
on the evaluation of changes related to blood stroke volume
over heart period. These two, if they are linked to ‘gold stan-
dard’ compliance, would allow for continuous monitoring in
various clinical scenarios, for instance, hydrocephalus ICP
monitoring or traumatic head injury (TBI) and subarachnoid
haemorrhage neuro-intensive care monitoring.
The infusion study is a type of volume–pressure test based
on the injection of additional volume into the cerebrospinal
space that allows for the estimation of compensatory parame-
ters, including cerebrospinal compliance, from amathematical
model of CSF circulation [13]. In the present work, we com-
pared compliance estimates obtained with the model of CSF
dynamics (the ‘gold standard’ method) during changes in the
mean ICP induced by constant rate infusion of fluid into the
CSF space in normal-pressure hydrocephalus (NPH) patients
with two other measures: based on the estimation of changes
in cerebral blood volume (CBV) in each cardiac cycle and
based on the analysis of changes in the ratio of characteristic
peaks P1 and P2 of ICP pulse waveform. The study offers new
insight into the feasibility of using the P1/P2 ratio and evalu-
ation of changes in CBV as a tool for continuous monitoring
of compliance of the cerebrospinal space.
Materials and methods
Data acquisition
Data from patients who underwent infusion studies with
simultaneous recording of ICP and cerebral blood flow
velocity (CBFV) signals at Addenbrooke’s Hospital
(Cambridge, UK) between 1993 and 1998 were selected
for retrospective analysis in this study. Selection of pa-
tients was made on a basis of good quality of ICP pulse
waveform and CBFV recording, and only those tests
where the shape of the pulse waveform of ICP presented
both P1 and P2 peaks were classified as suitable for anal-
ysis. Out of the full group of 72 considered recordings, 36
were chosen. Sixteen recordings (22%) were excluded be-
cause of rounded ICP pulse waveform that did not allow
for the identification of both characteristic peaks, and 20
recordings (28%) were excluded due to insufficient qual-
ity of either ICP or CBFV signals. The data were collect-
ed as part of routine clinical investigation following diag-
nosis of NPH. Ethics committee approval to record ICP
and CBFV using transcranial Doppler (TCD) ultrasonog-
raphy was obtained.
The computerized infusion test was performed with two
hypodermic needles (25 gauges). One of the needles was
used for ICP measurement and connected to a pressure
transducer through a saline-filled tube. The second needle
was used for infusion and connected to an infusion pump
containing a pressure amplifier (Simonsen & Will, Sidcup,
UK). The infusion of normal saline into the CSF space was
performed at the rate of 1.5 ml/min. The test began with
10 min of baseline recording of ICP before the start of the
infusion. Infusion continued until the increase in ICP
reached either the plateau phase or the maximum accept-
able level of 40 mm Hg, and the recordings were further
collected until ICP returned to baseline level. CBFV in the
middle cerebral artery was monitored during the test using
a TCD unit (Neuroguard; MedaSonics, Fremont, CA,
USA) with a 2-MHz probe locked in a stable position using
a commercially available fixation system. Twenty-six re-
cordings included also arterial blood pressure (ABP) mon-
itored noninvasively using a photoplethysmographic sys-
t em (Finapres ; F inap res Medica l Sys t ems , the
Netherlands).
An analogue-to-digital converter (DT 2814; Data
Translation, Marlboro, USA) connected to an IBM AT laptop
computer (Amstrad ALT 386 SX; Amstrad, Brentwood, UK)
was used for the collection of data from the pressure monitors
and the TCD system. The signals were sampled at frequency
ranging from 30 to 50 Hz using custom software for wave-
form recording (WREC;W. Zabolotny,WarsawUniversity of
Technology, Warsaw, Poland). An illustrative example of re-
corded signals is presented in Fig. 1.
Three methods of estimation of cerebrospinal
compliance
The relationship between pressure and volume in the intracra-
nial space is described by an exponential function known as
the pressure–volume curve, which shows that changes in ICP
increase progressively with the mean ICP [29]. Traditionally,
measurement of the pressure response requires external ma-
nipulation of intracranial volume, such as bolus injection or
constant rate infusion [18, 24]. A different approach to com-
pliance estimation relies on the possibility of measuring
changes in CBV alongside ICP. However, a method based
on magnetic resonance imaging [1], although potentially ac-
curate, is currently only applicable to the evaluation of instan-
taneous, or ‘snapshot’, values, and continuous estimation of
changes in CBV using TCD recordings of CBFV in large
cerebral arteries [19] does not allow for calibration of obtained
values due to the unknown cross-sectional area of insonated
vessels.
It has also been suggested that information about cerebral
compliance may be extracted from the pulse waveform of ICP
itself [6]. Three major features commonly used to characterize
ICP pulse waveform are peaks P1, P2, and P3 [16]. Although
the precise origin of those peaks is not universally agreed
upon, the shape of the ICP waveform is believed to arise from
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changes in both ABP and CBV [7]. Under normal circum-
stances, P1 dominates over the other two peaks, resulting in
a saw-tooth appearance of the waveform (Fig. 2a). As the
mean ICP increases, so does the amplitude of characteristic
peaks. However, the change is not uniform, and rising prom-
inence of P2 (Fig. 2b) eventually leads to a rounded or trian-
gular waveform with indistinguishable P1 and P3 [9, 10].
Given the relatively larger changes in the magnitude of the
P2 component, it has been suggested that the ratio of peak
amplitudes, P1/P2, may provide information about cerebral
compliance. Still, despite its potential as a means for long-
term monitoring of the state of the cerebrospinal space, very
little attention has been devoted to the application of this pa-
rameter in the evaluation of cerebral compensatory reserve.
In the present study, three methods were used to obtain
estimates of cerebrospinal compliance: (a) based on a model
of CSF dynamics, (b) based on evaluation of changes in CBV,
and (c) based on the ICP pulse waveform. Assessment of
model-based parameters describing CSF dynamics (a) was
performed using built-in algorithms of specialized software
(ICM+; Cambridge Enterprise, Cambridge, UK). All other
analyses were performed using programmes custom-written
in Python 3.8.
Model of cerebrospinal fluid dynamics
The first estimate of cerebrospinal compliance (denoted CCSF
from ‘cerebrospinal fluid dynamics’) was obtained from a
ma thema t i c a l mode l o f CSF vo lume–p r e s su r e
compensation [12]. Under normal conditions, in the absence
of long-term fluctuations in cerebral blood volume, it is as-
sumed that the production of CSF is balanced by its storage
and reabsorption. Including external CSF infusion, this can be
described by the following relationship:
production of CSFþ infusion
¼ storage of CSFþ reabsorption of CSF ð1Þ
The rate of CSF production is assumed to be constant. I(t)




Fig. 1 Illustrative example of signals recorded during the infusion test for a single patient. Grey vertical lines indicate the start and end of constant rate
(1.5 ml/min) infusion. a Intracranial pressure (ICP). b Cerebral blood flow velocity (CBFV). c Arterial blood pressure (ABP)
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the present study). The rate of CSF storage (Is) is proportional
to cerebrospinal compliance (C) and depends on the derivative
of CSF pressure (P) over time (dP/dt):
I s ¼ C dPdt ð2Þ
Compliance is in turn inversely proportional to the gradient
of CSF pressure and reference pressure (P0):
C ¼ 1
E P−Poð Þ ð3Þ
where E is cerebral elasticity. The rate of CSF reabsorption
(Ir) is proportional to the gradient between CSF pressureP and
pressure in the sagittal sinuses (Pss):
I r ¼ P−PssRout ð4Þ
where Rout describes the resistance to CSF outflow.
Relationship (3) is considered valid only above certain pres-
sure level described as ‘lower breakpoint pressure’. It is the
pressure above which the cerebrospinal pressure–volume
curve becomes exponential. Below this pressure, the
pressure–volume relationship is linear. The combination of







¼ I tð Þ ð5Þ
where Pb is the baseline pressure.
Parameters Rout, E, and P0 were estimated for ICP record-
ings used in this study based on the analytical solution of Eq.
(5) for constant rate infusion. E and P0 were then used to
obtain estimates of cerebrospinal compliance over the course
of the infusion test from Eq. (3). To maintain cohesion with
the other two pulse-by-pulse methods of estimation, the mean
ICP over each cardiac cycle was taken as P(t).
Evaluation of pulsatile changes in cerebral blood volume
The second estimate of cerebrospinal compliance (denoted
CCaBV from ‘cerebral arterial blood volume’) was obtained
from a mathematical model of cerebral blood circulation using
the approach described by Kim et al. [19]. The change in CBV
over a single cardiac cycle can be expressed as the difference
between arterial inflow (CBFa) and venous outflow (CBFv):
ΔCBV tð Þ ¼ ∫tt0 CBFa sð Þ−CBFv sð Þð Þds ð6Þ
where t0, t are the beginning and end of the cardiac cycle,
respectively, and s is the variable of integration. Given the
assumption that venous outflow has low pulsatility compared
to arterial inflow, the former can be approximated by a con-
stant flow equal to averaged arterial inflow:
ΔCaBV tð Þ ¼ ∫tt0 CBFa sð Þ−meanCBFað Þds ð7Þ
a b
Fig. 2 Illustrative examples of intracranial pressure (ICP) pulse wave-
forms from two different patients. Location of peaks P1 and P2 is indi-
cated by cross (P1) and star (P2) signs. ICP signals are plotted with solid
black lines. Additional signals used in the process of peak detection are
plotted as dashed (arterial blood pressure (ABP)) and dotted (cerebral
arterial blood volume (CaBV)) lines. All signals are normalized and
aligned with regard to pulse onset location. Vertical lines indicate the
correlation between the position of peaks P1 and P2 and the local maxima
of the ABP (dashed line) and CaBV (dotted line) waveforms, respectively
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Furthermore, cerebral arterial blood flow can be
expressed as cerebral blood flow velocity multiplied by
cross-sectional area of the vessel. Using TCD recordings
of CBFV in cerebral arteries and assuming that the cross-
sectional area of insonated vessel remains constant, Eq.
(7) can be approximated as
ΔCaBV nð Þ ¼ Sa  ∑ni¼1 CBFVa ið Þ−meanCBFVað ÞΔt ið Þ ð8Þ
where n is the number of samples from the beginning of the
cardiac cycle,Δt is the time interval between two consecutive
samples, and Sa is the unknown cross-sectional area of
insonated vessel.
Based on pulsatile signals CaBV and ICP, cerebrospinal




where AMPCaBV and AMPICP are the amplitudes of funda-
mental components of CaBV and ICP, respectively. However,
due to unknown Sa, resulting values of C cannot be calibrated
in units of ml per mm Hg.
In this study, CaBV was estimated from Eq. (8) based on
CBFV recordings in the middle cerebral artery. Peak-to-peak
amplitudes of CaBV and ICP in each cardiac cycle were then
used to obtain pulse-by-pulse estimates of cerebrospinal com-
pliance using Eq. (9).
ICP waveform analysis
The third estimate of cerebrospinal compliance (denoted CP1/
P2 from the P1/P2 amplitude ratio) was based on the analysis
of the ICP pulse waveform. Prior to the analysis, ICP, CBFV,
and ABP (where available) signals were filtered using a low-
pass filter with the cut-off frequency of 10 Hz. Individual
pulses in the ICP signal were identified using a modified
Scholkmann algorithm [4]; corresponding sections of CBFV
and ABP signals were extracted based on pulse onset loca-
tions from ICP. For the purpose of peak annotation, each pulse
was normalized and linearly detrended, and the three signals
were aligned with regard to pulse onset in order to remove the
phase shift resulting from distance between measurement
sites.
A semi-automated algorithm based on the detection of
the local maxima was used for peak identification. The
algorithm incorporated information about the local maxi-
ma of ABP and CaBV (derived from the CBFV signal
using Eq. (8)), taking into account observations from pre-
vious studies which showed that P1 is associated with the
propagation of the pulse pressure wave through cerebral
arteries and usually coincides with the systole of ABP,
while P2 is derived from arterial blood volume load and
coincides with the maximum of CaBV [8, 15]. In each
pulse waveform, the local maxima of ICP corresponding
to the position of maxima in ABP and CaBV were select-
ed as candidates for P1 and P2, respectively. In the ab-
sence of the ABP signal, the first maximum of the CBFV
signal was used instead to identify P1 candidates. Full
detection results were reviewed and manually corrected
in cases of insufficient detection accuracy, particularly in
pathologically rounded waveforms. Pulses with distorted
ICP waveform or unidentifiable P1 and P2 were excluded
from further analyses. Illustrative examples of ICP pulse
waveforms with peak annotations are presented in Fig. 2.
The amplitude of peaks P1 and P2 in each pulse was
calculated as the vertical distance to the preceding local
minimum identified as pulse onset. Pulse-by-pulse P1/P2
amplitude ratio was then used as a compliance estimate.
Statistical analysis
Statistical analyses were performed using Python 3.8 with
the built-in methods included in the SciPy 1.5.0 package.
The Shapiro–Wilk test with a significance level of 0.05
was used to assess normality of data distributions. Upon
rejection of the normality hypothesis for most of the
analysed variables, non-parametric methods were chosen
to analyse the relationship between compliance estimates.
Time courses of compliance estimates obtained for indi-
vidual patients with each of the three methods were com-
pared with each other and with ICP using the Spearman
correlation coefficient. To reduce the effect of difference
in time scales used in compliance estimation, 30-pulse
moving averages were used.
In order to compare the ‘high’ and ‘low’ compliance
states reflecting the baseline and plateau phase of the in-
fusion test, 1-minute-long fragments of the recordings
where all three compliance estimates could be obtained
were selected manually. Due to significant distortion of
the ICP pulse waveform during baseline in a number of
recordings, the initial stage of infusion was selected in-
stead as baseline. Two patients for whom baseline values
were not available either due to low quality of the ICP
signal or the lower breakpoint pressure limit used in esti-
mation of CCSF were excluded from this part of the anal-
ysis. Values averaged over the baseline and plateau
phases of the infusion test were compared using the
Wilcoxon signed rank test. The same methods were used
to determine the significance of changes in amplitude of
peaks P1 and P2.
A significance level of 0.05 was assumed in all statistical





The mean age of the patients was 54 years (range, 27–76
years). The patients showed ventricular dilation marked by
increased bicaudate index (mean, 0.27; range, 0.14–0.39),
and 14% showed white matter ischemia. Initial ICP in the
group was 8.7 [3.8–11.4] mm Hg. Group-averaged Rout and
elasticity were 12.1 [8.9–15.8] mm Hg/(ml/min) and 0.19
[0.14–0.33] ml−1, respectively.
Amplitude of peaks P1 and P2 during changes in
mean ICP
Figure 3 shows an illustrative example of the time courses of
P1 and P2 amplitude during infusion test for a single patient.
The rise in the mean ICP during infusion resulted in an in-
crease in amplitude of both P1 and P2 (p < 10−6), with a
visibly larger change for P2: up to 6.22 [4.44–8.35] mm Hg
mm Hg from baseline amplitude of 3.52 [2.44–4.49] mm Hg
vs. 4.23 [2.7–4.74] mm Hg from baseline of 2.51 [1.44–3.56]
mm Hg for P1. While baseline P1/P2 ratio varied between
patients, with some patients exhibiting pronounced P1 (P1/
P2 > 1) and some already showing increased P2 (P1/P2 <
1), the P1/P2 ratio during plateau fell to around 1 and below.
Time courses of both amplitudes were strongly correlatedwith
changes in the mean ICP; however, slightly higher correlation
was observed for P2 (group-averaged correlation coefficient
equal 0.98 [0.93–0.99] vs. 0.95 [0.82–0.96] for P1). The mag-
nitude of decrease in P1/P2 ratio between baseline and plateau
phases was not correlated with either baseline ICP, change in
ICP, or elasticity estimated based on the CSF dynamics mod-
el. It showed weak although statistically significant, inverse
correlation with baseline P1/P2 ratio (R = –0.38, p = 0.03; Fig.
4), with largest changes observed in cases where baseline ICP
waveform contained P1 dominating over P2. Figure 5 shows
an example of changes in ICPwaveform between baseline and
plateau for patients with high and low baseline P1/P2 ratio.
Comparison of three estimates of cerebrospinal
compliance
Figure 6 shows an illustrative example of the time courses of
compliance estimates obtained with each of the three methods
for a single patient. Compliance estimates were positively and
statistically significantly (p < 0.05) correlated: 0.94 [0.88–
0.97] for CCSF vs. CCaBV, 0.77 [0.63–0.91] for CCSF vs. CP1/
P2, and 0.68 [0.48–0.91] for CCaBV vs. CP1/P2. Similarly, com-
pliance estimates CCaBV and CP1/P2 showed inverse correla-
tion with the mean ICP, although the correlation was stronger
for CCaBV (−0.82 [−0.71–−0.86]) than CP1/P2 (−0.71 [−0.46–
−0.79]); as CCSF was calculated using the mean ICP itself, this
pair of parameters was not compared.
Between baseline and plateau phase of the infusion test,
group-averaged mean ICP increased from 13.4 [9.5–16.5] to
22.6 [18.7–28.0] mm Hg. Accordingly, all three methods
showed a statistically significant decrease in compliance esti-
mates between baseline and plateau (Wilcoxon signed rank
test p-value < 10−4) but with a varying degree of absolute
changes, with the largest change observed for the values ob-
tained with the CaBVmodel (baseline vs. plateau, 1.16 [0.71–
1.75] cm/mm Hg vs. 0.72 [0.50–1.00] cm/mm Hg), smaller
for the CSF dynamics model (0.67 [0.37–1.16] ml/mm Hg vs.
Fig. 3 Illustrative example of
time courses of amplitude of
peaks P1 and P2 for a single
patient. Full pulse-by-pulse time
courses are presented as dots
while 30-pulse moving averages
are presented as solid lines. a
Mean intracranial pressure (ICP).
b Amplitude of peaks P1 (light
grey symbols) and P2 (dark grey
symbols) of the ICP pulse
waveform
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0.27 [0.17–0.51] ml/mmHg)), and smallest for the P1/P2 ratio
(0.69 [0.58–0.90] vs. 0.57 [0.46–0.74]). Decrease in compli-
ance estimates relative to baseline was 46.3% [36.5–65.1%],
41.0% [30.8–48.4%], and 16.4% [7.3–27.9%] for the CCSF,
CCaBV, and CP1/P2 method, respectively.
Discussion
The analysis of ICP pulse waveform, which relies on the as-
sumption that variations in the pulsatile component of ICP
reflect the pressure response to volume changes induced by
the flow of cerebral blood in each cardiac cycle [2], has been
the basis of various indirect methods of compensatory reverse
estimation proposed over the years, such as the amplitude–
pressure curve [31], high-frequency centroid [28], or RAP
index [11]. The P1/P2 ratio, although suggested as a measure
of cerebral compliance in the 1980s, so far has not been ex-
plored in much detail. A study by Cardoso et al. [6] showed
that hyperventilation-induced reduction in the mean ICP is
accompanied by a decrease in P2 and relatively small change
in P1, while similar reduction caused by head elevation or
CSF withdrawal has little to no effect on the shape of the pulse
waveform. It was suggested that this would indicate the de-
pendence of P2 on cerebral compliance. Results of the present
study are in accordance with previously reported observations
[6, 22]. Increase in the mean ICP caused by infusion of vol-
ume into the CSF space produced a noticeably larger change
in the amplitude of P2 for similar baseline amplitudes of P1
and P2, resulting in decreases in the P1/P2 ratio. Individual
time courses of the P1/P2 ratio followed the time courses of
compliance estimated based on the CSF dynamics model rel-
atively well, with mean correlation coefficient at the level of
0.75.
The differences in the time courses can be explained by the
dependence of CCSF on the trend in the mean ICP, used both in
the estimation of elasticity and P0 and further calculation of
compliance, as the P1/P2 ratio is calculated only from the shape
of the ICP waveform and on a pulse-by-pulse basis. However,
this effect was partially mitigated by the use of moving aver-
ages in correlation analysis. The slightly weaker correlation
with values of CCaBV may in turn be the effect of inclusion of
another signal, CBFV, in the model. Although the extent of
Fig. 4 Relationship between baseline P1/P2 ratio and change in P1/P2
ratio between baseline and plateau phases of infusion test. Values above
the scatter plot indicate Spearman correlation coefficient and its p-value
a b
Fig. 5 Illustrative examples of changes in intracranial pressure (ICP)
pulse waveform between baseline and plateau phases of infusion test.
Baseline and plateau phases are presented in the top and bottom plots,
respectively. Location of peaks P1 and P2 is indicated by cross (P1) and
star (P2) signs. a Patient with high baseline P1/P2 ratio. b Patient with
low baseline P1/P2 ratio
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decrease in compliance varied between methods, largely due to
varying range of values obtained with each approach, all three
methods allowed for statistically significant differentiation be-
tween the ‘high’ and ‘low’ compliance state associated with
baseline and plateau phases of the infusion test. However, as
the CaBV and P1/P2methods examine the ICP pulse waveform
resulting from unknown volume load, they are indirect mea-
sures that cannot be translated to units of compliance, and
straightforward comparison of the values is not feasible.
Table 1 outlines major features and limitations of each method
of compliance estimation considered in this study.
One advantage of assessing cerebral compliance based on
the P1/P2 ratio is the fact that it does not depend on external
volumetric manipulation necessary to derive the pressure–
volume curve. In principle, the method also does not require
any additional signals beside ICP that are needed to estimate
changes in CBV. It should be noted, however, that the major
difficulty lies in reliable, fully automated detection of peaks P1
and P2. A number of algorithms of often impressive complexity
have been proposed over the years for the task of ICP peak
identification [5, 14, 17, 30]. Those methods remain a relatively
recent development in the continuously advancing field of bio-
medical signal processing, and despite promising results report-
ed so far, they are yet to find acceptance in the medical com-
munity and most importantly validation in large scale trials that
would allow for introduction to standard clinical practice. Still,
the ICP pulse waveform exhibits large inter- and intrapatient
differences, with varying height and prominence of character-
istic peaks that may not all be visible even in patients with
normal compliance. Whereas the detection of P2 is usually
possible despite pathological rounding of the pulse, the detec-
tion of P1 becomes unachievable. Incorporation of the ABP
signal may improve general peak identification accuracy by
allowing for better differentiation between P1 and P2 candi-
dates. Nevertheless, the P1/P2 ratio approach relies heavily on
the performance of the underlying detection algorithm, and that
in turn requires that the signal is recorded with sufficiently good





Fig. 6 Illustrative example of time courses of compliance estimates for a
single patient. Full pulse-by-pulse time courses are presented as grey
lines, while 30-pulse moving averages are presented as black lines. a
Mean intracranial pressure (ICP). b–d Compliance estimates obtained
with b CSF dynamics model (CCSF), c cerebral blood volume model
(CCaBV) and d P1/P2 peak ratio of ICP pulse waveform (CP1/P2)
Acta Neurochir
In the present study, in order to provide as reliable as possible
assessment of the feasibility of using the P1/P2 ratio as an esti-
mate of cerebrospinal compliance, P1 and P2 candidates identi-
fied by the algorithm using both the analysis of ICP pulse wave-
form and its relationship with ABP (where available), CBFV,
and CaBV signals were manually reviewed and corrected in
cases of insufficient detection accuracy. In order to consider
validating this approach in the clinical setting, further work is
required to refine the prototype and develop it into a fully auto-
mated method of peak identification. Moreover, a comprehen-
sive solution would not only need to be capable of analysing in
real time the large variety of ICP pulse waveform shapes en-
countered in patients with intracranial pathologies but also de-
tecting artefacts and selecting pulses where the peaks, particu-
larly P1, become impossible to distinguish due to the rounding
of the waveform and not due to the low quality of the signal.
On the other hand, assuming that the peaks are identified
reliably, it is theoretically possible to compare the results be-
tween separate measurements and between individuals. A pre-
vious study by Fan et al. [15] attempted to use the P2/P1 ratio
(as opposed to the P1/P2 ratio used in the present study) as a
predictor of disproportionate increases in ICP in TBI patients.
Elevated P2 amplitude was signified by P2/P1 ratio equal to or
exceeding 0.8. The study showed that the P2/P1 ratio, while
not a unique predictor of intracranial hypertension episodes,
was significantly higher in the group exhibiting ICP increases.
A different study in paediatric hydrocephalus patients con-
firmed the applicability of the P2/P1 ratio in the identification
of intracranial hypertension and assessment of the response to
shunting [3]. It should be noted that other works focused on
the classification of ICP pulse waveform patterns [14, 26]
suggested that decrease in compliance is associated with P2
visibly dominating over P1. A threshold ratio of 0.8 could
therefore potentially lead to the inclusion of normal wave-
forms in the elevated P2 group and influence the results.
Ultimately, the use of the P1/P2 ratio as an indicator of
decreased buffering capacity of the cerebrospinal system
would require further investigation with regard to the correla-
tion between the value of P1/P2 ratio and the clinical status of
the patient, as this measure cannot be directly converted to
units of compliance. Given earlier reports on the relationship
between measures of compliance and compensatory reserve
and outcome in TBI patients [25, 27, 28, 32], combined with
the possibility of continuously recording the ICP waveform in
modern neuro-critical care units, this avenue of study seems
nonetheless to be a promising one.
Limitations
Compliance estimation based on the evaluation of changes in
CBV as used in this study is based on a number of assump-
tions, including constant diameter of insonated vessels during
TCD recording. Due to unknown cross-sectional area of the
vessels, CCaBV values cannot be calibrated in units of compli-
ance. The same applies to the P1/P2 ratio as changes in the
ICP pulse waveform are analysed as a response to unknown
blood stroke volume. Consequently, direct comparison be-
tween those two methods and the ‘gold standard’ approach
based on the model of CSF dynamics was limited to the cor-
relation between the time courses.
Moreover, this study was performed as a retrospective analy-
sis of infusion test recordings of the ICP signal with the addition-
al requirement of availability of simultaneously collected CBFV.
As TCD measurements are not part of routine clinical investiga-
tion in NPH patients, the number of available recordings was
limited, and given the size of the study group, the results of this
study should be regarded as preliminary. Considered recordings
were not collected with the explicit purpose of analysing the ICP
pulse waveform in detail, which led to a relatively high
Table 1 Comparison of three methods of cerebrospinal compliance estimation
Characteristic Method
Based on the model of CSF
dynamics
Based on the evaluation of
CaBV from TCD recordings
Based on the analysis of the
P1/P2 ratio of ICP pulse waveform
Units Absolute [ml/mm Hg] Express compliance per unit of
cross-sectional area of insonated
vessel
[cm/mm Hg]
Relative changes only [dimensionless]
Assessment One-off measurement (based
on a recording from entire
infusion test)
Continuous but limited by positioning
of TCD probes
Continuous
Accuracy Good Relative changes only Relative changes only
Availability Always when access to CSF space
is possible
Requires TCD monitoring Requires that P1 and P2 are detectable
in the ICP pulse waveform
Additional requirements Requires invasive ICP measurement Requires invasive ICP measurement
(with good quality of pulse waveform)
Requires invasive ICP measurement
(with good quality of pulse waveform)
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percentage of cases (almost 30% of the initial dataset) excluded
on the basis of low signal quality.
However, even assuming sufficiently high quality of the sig-
nal, the visibility of peaks remains a significant limitation. On the
other hand, pulses with indistinguishable P1 due to the rounding
of the waveform constitute a separate class of signals. Whereas
they do not allow for monitoring of relative changes over time,
they could be incorporated as a form of low compliance indica-
tor. This could be a viable solution especially in long-term mon-
itoring aimed at detecting decreases in compensatory reserve,
where peak visibility is expected to vary.
Conclusions
Apart from the ‘gold standard’ method, compliance of the
cerebrospinal fluid system may be evaluated using pulse
waveform of ICP and TCD recordings of blood flow velocity
in the cerebral arteries. The latter two methods agree with the
‘gold standard’ approach based on volume addition. It poten-
tially opens new perspectives for continuous brain compliance
monitoring in various clinical scenarios.
List of abbreviations ABP, Arterial blood pressure [mm Hg]; CBFV,
Cerebral blood flow velocity [cm/s]; CBV, Cerebral blood volume [ml];
CSF, Cerebrospinal fluid; ICP, Intracranial pressure [mm Hg]; NPH,
Normal-pressure hydrocephalus; TBI, Traumatic brain injury; TCD,
Transcranial Doppler
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